文献速递类风湿关节炎

靶向CD6减轻小鼠胶原诱导性关节炎

Attenuation of Murine Collagen-Induced Arthritis by Targeting CD6.
PubMed 文献 · Arthritis Rheumatol · 2020-08-14

研究利用CD6基因敲除小鼠和CD6人源化小鼠的胶原诱导性关节炎(CIA)模型,发现CD6缺失可降低胶原特异性Th9和Th17反应、关节促炎细胞因子及血清总IgG和IgG1水平,并减少关节血红蛋白含量;在CD6人源化小鼠中注射抗人CD6单克隆抗体同样减轻关节炎症。

要点

  • CD6缺失选择性抑制胶原特异性Th9和Th17反应,不影响Th1反应。
  • CD6缺失降低关节促炎细胞因子和血清胶原反应性总IgG及IgG1水平。
  • 抗人CD6单克隆抗体在CD6人源化小鼠中减轻CIA关节炎症。

核心结论

  • CD6与其配体的相互作用对CIA的持续和T细胞驱动的炎性关节炎具有重要作用。

研究设计与样本

  • 使用野生型(WT)和CD6基因敲除(CD6-KO)小鼠以胶原乳剂免疫诱导CIA。
  • 在CD6人源化小鼠(T细胞表达人CD6替代小鼠CD6)中,于第7、14、21天注射小鼠抗人CD6 IgG(UMCD6)或对照IgG进行干预。
  • 评估关节组织损伤、白细胞浸润、局部炎性细胞因子、胶原特异性Th1/Th9/Th17反应及血清胶原特异性IgG亚类。

主要发现

  • CD6缺失降低胶原特异性Th9和Th17反应,但不降低Th1反应。
  • CD6缺失降低关节多种促炎细胞因子水平。
  • CD6缺失降低血清胶原反应性总IgG和IgG1水平,但不降低IgG2a和IgG3水平。
  • CD6-KO CIA小鼠关节匀浆血红蛋白含量较WT CIA小鼠显著降低(P < 0.05),提示血管生成减少。
  • 在CD6人源化小鼠中,抗人CD6单克隆抗体治疗同样有效减轻CIA关节炎症。

临床怎么用

  • 靶向CD6可能为T细胞驱动的炎性关节炎(如类风湿关节炎)提供潜在治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: CD6 is an important regulator of T cell function that interacts with the ligands CD166 and CD318. To further clarify the significance of CD6 in rheumatoid arthritis (RA), we examined the effects of targeting CD6 in the mouse model of collagen-induced arthritis (CIA), using CD6-knockout (CD6-KO) mice and CD6-humanized mice that express human CD6 in lieu of mouse CD6 on their T cells. METHODS: We immunized wild-type (WT) and CD6 gene-KO mice with a collagen emulsion to induce CIA. For treatment studies using CD6-humanized mice, mice were immunized similarly and a mouse anti-human CD6 IgG (UMCD6) or control IgG was injected on days 7, 14, and 21. Joint tissues were evaluated for tissue damage, leukocyte infiltration, and local inflammatory cytokine production. Collagen-specific Th1, Th9, and Th17 responses and serum levels of collagen-specific IgG subclasses were also evaluated in WT and CD6-KO mice with CIA. RESULTS: The absence of CD6 reduced 1) collagen-specific Th9 and Th17, but not Th1 responses, 2) the levels of many proinflammatory joint cytokines, and 3) serum levels of collagen-reactive total IgG and IgG1, but not IgG2a and IgG3. Joint homogenate hemoglobin content was significantly reduced in CD6-KO mice with CIA compared to WT mice with CIA (P < 0.05) (reduced angiogenesis). Moreover, treating CD6-humanized mice with mouse anti-human CD6 monoclonal antibody was similarly effective in reducing joint inflammation in CIA. CONCLUSION: Taken together, these data suggest that interaction of CD6 with its ligands is important for the perpetuation of CIA and other inflammatory arthritides that are T cell driven.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Li Y, Ruth JH, Rasmussen SM, et al. Attenuation of Murine Collagen-Induced Arthritis by Targeting CD6. Arthritis Rheumatol. 2020. PMID: 32307907. doi:10.1002/art.41288

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。